Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function - Wikidata - awgldk - TriplyDB

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

http://www.wikidata.org/entity/Q28287075

about

Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling Trace amine-associated receptor 1-Family archetype or iconoclast?Analysis of human TAAR8 and murine Taar8b mediated signaling pathways and expression profile Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern Incretin-like effects of small molecule trace amine-associated receptor 1 agonists.New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine.Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes.Thyroid hormone signaling in energy homeostasis and energy metabolism.ApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation.Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum Identification and quantification of 3-iodothyronamine metabolites in mouse serum using liquid chromatography-tandem mass spectrometry.NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR(1)).The pharmacology and molecular mechanisms underlying temperature regulation and torpor.Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine.Thyronamines are isozyme-specific substrates of deiodinases.Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.Induction of torpor: mimicking natural metabolic suppression for biomedical applications.Update on 3-iodothyronamine and its neurological and metabolic actions.Emerging role of thyroid hormone metabolites.Tissue thyroid hormones and thyronamines.Characterization of 3-iodothyronamine in vitro dynamics by mathematical modeling.3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo.THE SYNTHESIS OF 13C9-15N-LABELED 3,5-DIIODOTHYRONINE AND THYROXINE.Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity.Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.Modulation of cardiac ionic homeostasis by 3-iodothyronamine.Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo.The Case for TAAR1 as a Modulator of Central Nervous System Function.Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.Proof of Concept of the Electrochemical Sensing of 3-Iodothyronamine (T1AM) and Thyronamine (T0AM)

P2860

Q21129458-E3A15994-0F49-44D5-AC0E-7C0F9B024415 Q24634650-23852BBF-4981-4D0D-8AD2-2418A302C021 Q24648381-BD86C0A2-8898-48C3-B0DA-5F47541781E6 Q24648659-799837F5-6F7B-4AED-8DFB-7C404E079E09 Q28251480-4D3669E0-27F8-4988-8730-4599639CA002 Q28544799-B35CCE2E-73DD-4390-B111-7238B9BA7084 Q34512348-D4155795-D0CD-4A9C-A608-2BDBA999F1B1 Q34545052-B9A0FCBC-0B88-4621-B419-276A95BCA1C1 Q35180639-38C3D800-163C-4A7B-9B6D-FE980EBA7C7B Q35671563-96275E36-5B85-42C2-AE90-404ED2B80C29 Q35693962-568C4D09-D6AE-4478-A949-25C7B1862238 Q36655479-ADF51A59-719F-417A-A0B9-4CE9FE8682CF Q36721059-2B864C9A-3096-4707-BB36-60A34B6C4788 Q36721071-4CBE83FA-C118-480E-838A-93A46CA236FC Q36955148-C020A0E2-6367-4B38-AD4F-5DBE0BD86777 Q37125976-34B21852-84D5-4751-8C8B-9F2222CAA5E3 Q37179691-A684464F-365A-44C8-B2EC-B09F5A496CD5 Q37222883-DD30BA54-E18F-418F-B496-EE475CC17983 Q37251775-99A02021-013B-49B2-8E9C-20D77AC0A280 Q37325285-DA582653-9798-49F8-BDC7-033571F733B3 Q37599600-584C8704-1A70-4071-852C-6D2658B4127B Q37734776-A45BD125-2EDD-4DC2-961A-68C225901E3C Q37880727-7F322879-E9E9-4CAA-AA63-788F85A1163A Q38264120-864FA7A0-7306-44F3-ADCF-E91CCF7CDFC7 Q38691344-71FF65D6-A8EC-4999-9392-7F99CAAF2A69 Q38817930-10E5EF2B-E2B5-4B38-B5FD-36213D8A2BBA Q39145530-7C8999F6-4301-4FD4-BC77-69C70841EF06 Q41234180-76E3ADB2-16C3-4B3E-B33C-32D771526F0D Q41710479-73CC385E-F8AF-4C34-B3F4-D26F562E138F Q41772850-62DC299B-1744-48A8-8AC7-7C848B774615 Q41870882-D4AB5593-9435-474C-91B2-81715B8F6793 Q41877712-F05EFFB5-A132-4321-813B-ED0B23F84BE2 Q42042391-B601EAFA-20EF-4812-A34A-6A264527776D Q42724891-35A22B28-143C-4D90-9730-DAE15F541016 Q47640093-70BBDE12-0971-4F27-A0EB-38A12978223E Q52653144-7B6ED01A-AF95-4588-A485-925F3D599E33 Q54108127-F1E96BF8-770D-4836-BA7D-B22D19909079 Q58758130-3A6F265F-1524-4687-A533-00F2283C0589

P2860

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

http://www.wikidata.org/entity/Q28287075

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@ast

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@en

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@nl

type

label

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@ast

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@en

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@nl

prefLabel

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@ast

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@en

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@nl

P1433

Q28287075-5B8492E3-252E-4469-90E9-40340BFD6A11

P1476

Q28287075-58248C46-4055-4DF5-933F-9551F3EB19AA

P2093

Q28287075-0807064F-710A-4AA8-AF7C-438EC0B2572E

Q28287075-09D0B607-7B42-4DAA-BF5B-EDC5B0A900B7

Q28287075-26031190-E771-440C-BE88-898B7B4D13A3

Q28287075-2C32E4B9-20C6-4E89-BCDF-D2883531C675

Q28287075-631A3821-F4A7-4794-B76B-9EC2C82B82E8

Q28287075-69F5BFF1-D231-49E1-B20E-EB49A6F6B810

Q28287075-7CA5CB8E-384E-42DA-9840-E0406258978B

Q28287075-ADCBC876-03A7-48D5-A55E-585FDBCFBD1E

Q28287075-C6DC9A26-C0ED-4A8E-A375-38D8731F88DB

Q28287075-D89A6D20-15EA-4E86-A523-37F8A685C8BB

P304

Q28287075-382C4D6C-A377-4A52-8000-B6B935566694

P31

Q28287075-73FE9808-677C-4AAC-8992-52AD47DA002D

P356

Q28287075-2D291157-E17B-4C54-92CC-566B6D886095

P407

Q28287075-E8156141-2452-41E1-B2CC-A85FE3B0BE94

P433

Q28287075-9A474B03-8007-4F10-83A1-E65F256F1912

P478

Q28287075-E6D181C2-6C4C-498B-94C6-9FB8416B5A0A

P50

Q28287075-30BA97D2-BD21-4459-980B-0E689EB5A10C

Q28287075-F35FD6AB-D01E-49C8-90E8-61F521882C81

P577

Q28287075-3936C025-162A-4121-AAB1-E10F553F02B6

P5875

Q28287075-7C3FF8B9-6817-48ED-8B71-114C646179BA

P698

Q28287075-375BB384-BA2A-42D5-9C5E-7D2693275F64

P356

P1433

P1476

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

@en

P2093

Andrea DeBarber

http://www.w3.org/2001/XMLSchema#string

David K Grandy

http://www.w3.org/2001/XMLSchema#string

Grazia Chiellini

http://www.w3.org/2001/XMLSchema#string

Sabina Frascarelli

http://www.w3.org/2001/XMLSchema#string

Sandra C Tobias

http://www.w3.org/2001/XMLSchema#string

Sandra Ghelardoni

http://www.w3.org/2001/XMLSchema#string

Simona Brogioni

http://www.w3.org/2001/XMLSchema#string

Simonetta Ronca-Testoni

http://www.w3.org/2001/XMLSchema#string

Thomas S Scanlan

http://www.w3.org/2001/XMLSchema#string

Vittoria Carnicelli

http://www.w3.org/2001/XMLSchema#string

P304

1597-1608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.06-7474COM

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Elisabetta Cerbai

Riccardo Zucchi

P577

2007-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6521208

http://www.w3.org/2001/XMLSchema#string

P698

17284482

http://www.w3.org/2001/XMLSchema#string